Berman Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $324K | Buy |
1,148
+27
| +2% | +$7.62K | 0.05% | 187 |
|
2021
Q2 | $387K | Buy |
1,121
+349
| +45% | +$120K | 0.06% | 147 |
|
2021
Q1 | $215K | Sell |
772
-6
| -0.8% | -$1.67K | 0.04% | 181 |
|
2020
Q4 | $190K | Buy |
778
+89
| +13% | +$21.7K | 0.05% | 172 |
|
2020
Q3 | $195K | Sell |
689
-30
| -4% | -$8.49K | 0.06% | 149 |
|
2020
Q2 | $192K | Hold |
719
| – | – | 0.05% | 147 |
|
2020
Q1 | $227K | Buy |
719
+60
| +9% | +$18.9K | 0.07% | 108 |
|
2019
Q4 | $195K | Buy |
659
+10
| +2% | +$2.96K | 0.06% | 138 |
|
2019
Q3 | $151K | Buy |
649
+5
| +0.8% | +$1.16K | 0.05% | 160 |
|
2019
Q2 | $150K | Buy |
644
+106
| +20% | +$24.7K | 0.05% | 159 |
|
2019
Q1 | $127K | Buy |
538
+17
| +3% | +$4.01K | 0.04% | 166 |
|
2018
Q4 | $155K | Buy |
+521
| New | +$155K | 0.06% | 123 |
|